Progyny (NASDAQ: PGNY) reported Q2 EPS of $0.43, $0.26 better than the analyst estimate of $0.17. Revenue for the quarter came in at $304.1 million versus the consensus estimate of $305.32 million.

GUIDANCE:

Progyny sees Q3 2024 EPS of $0.35-$0.38, versus the consensus of $0.43. Progyny sees Q3 2024 revenue of $290-303 million, versus the consensus of $326.2 million.

Progyny sees FY2024 EPS of $1.53-$1.61, versus the consensus of $1.64. Progyny sees FY2024 revenue of $1.165-1.2 billion, versus the consensus of $1.237 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.